198 related articles for article (PubMed ID: 8707088)
21. Definition and evaluation of mucosal healing in clinical practice.
Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
[TBL] [Abstract][Full Text] [Related]
22. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
23. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
Lemberg DA; Clarkson CM; Bohane TD; Day AS
J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
[TBL] [Abstract][Full Text] [Related]
24. Eicosanoid levels in bronchoalveolar lavage fluid of young female smokers and non-smokers.
Zijlstra FJ; Vincent JE; Mol WM; Hoogsteden HC; Van Hal PT; Jongejan RC
Eur J Clin Invest; 1992 May; 22(5):301-6. PubMed ID: 1592082
[TBL] [Abstract][Full Text] [Related]
25. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
26. Bacterial peptides enhance inflammatory activity in a rat model of colitis.
García-Lafuente A; Antolín M; Guarner F; Vilaseca J; Malagelada JR
Digestion; 1996; 57(5):368-73. PubMed ID: 8886582
[TBL] [Abstract][Full Text] [Related]
27. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
28. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
29. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
30. Abnormal neutrophil phenotype and neutrophil FcRIII deficiency corrected by bone marrow transplantation.
Minchinton RM; de Haas M; von dem Borne AE; Kleijer M; Roberts AW; Gillett EA
Transfusion; 1995 Oct; 35(10):874-8. PubMed ID: 7570921
[TBL] [Abstract][Full Text] [Related]
31. Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis.
Gertner DJ; Rampton DS; Madden MV; Talbot IC; Nicholls RJ; Lennard-Jones JE
Gut; 1994 Oct; 35(10):1429-32. PubMed ID: 7959200
[TBL] [Abstract][Full Text] [Related]
32. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
33. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease.
Leach ST; Messina I; Lemberg DA; Novick D; Rubenstein M; Day AS
Inflamm Bowel Dis; 2008 Jan; 14(1):68-74. PubMed ID: 17879274
[TBL] [Abstract][Full Text] [Related]
34. Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease.
Arnott ID; Drummond HE; Ghosh S
Scott Med J; 2001 Oct; 46(5):136-9. PubMed ID: 11771492
[TBL] [Abstract][Full Text] [Related]
35.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
36. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
37. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.
Meenan J; Grool TA; Hommes DW; Dijkhuizen S; ten Kate FJ; Wood M; Whittaker M; Tytgat GN; van Deventer SJ
Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):569-73. PubMed ID: 8823572
[TBL] [Abstract][Full Text] [Related]
38. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
[TBL] [Abstract][Full Text] [Related]
39. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
40. Increased concentrations of eosinophilic cationic protein in whole-gut lavage fluid from children with inflammatory bowel disease.
Troncone R; Caputo N; Esposito V; Campanozzi A; Campanozzi F; Auricchio R; Greco L; Cucchiara S
J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):164-8. PubMed ID: 9932849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]